Piper Jaffray Upgrades Celgene (CELG) to Overweight

Go back to Piper Jaffray Upgrades Celgene (CELG) to Overweight

RBC Capital Upgrades Celgene (CELG) to Outperform

January 8, 2013 6:53 AM EST

RBC Capital upgraded Celgene (NASDAQ: CELG) from Sector Perform to Outperform with a price target of $100.00 (from $90.00).

For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.

Shares of Celgene closed at $85.73 yesterday, with a 52 week range of $58.53-$85.94.... More